Trasylol News
Bayer anti-bleeding drug linked to 50 per cent higher death rate than alternatives
-Orillia Packet & Times
05/16/2008- An expensive drug used to minimize severe bleeding during heart surgery actually significantly increased the risk that patients would die during surgery or in the 30 days following, a Canadian study comparing the drug to two far cheaper alternatives shows.
Called the BART trial, the study found people who received Trasylol or aprotinin (its generic name) were 53 per cent more likely to die than people who received the other anti-bleeding agents, tranexamic acid or aminocaproic acid.
Ennis & Ennis, P.A. is representing individuals that have been harmed as a result of Trasylol side effects. If you or a loved one have suffered as a result of Trasylol side effects such as kidney failure, heart attack, or stroke you may be entitled to compensation. For more information about a Trasylol lawsuit, a possible Trasylol recall, or for questions regarding Trasylol class action lawsuits fill out our free Trasylol case evaluation . Our on-staff nurse and attorneys are standing by to answer any questions you may have regarding Trasylol side effects, a possible Trasylol class action lawsuit, or any other type of Trasylol litigation.